{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/conjunctivitis-allergic/background-information/complications/","result":{"pageContext":{"chapter":{"id":"923b6415-5fe1-550a-baf5-89285f8ddf77","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field 1860c66a-02e2-4cb4-992e-7b8e536463d0 --><h2>What are the complications?</h2><!-- end field 1860c66a-02e2-4cb4-992e-7b8e536463d0 -->","summary":"","htmlStringContent":"<!-- begin item ed990ecf-56e5-4af6-a087-0473179037b1 --><!-- begin field 3b58b079-4dcf-4dad-afb4-1823ccb947b6 --><ul><li>In most cases, conjunctivitis does not cause permanent visual loss or structural damage.</li><li><strong>Seasonal allergic conjunctivitis and perennial allergic conjunctivitis</strong> (the commonest forms of allergic conjunctivitis) can lead to:<ul><li>Irritability, decreased concentration and daytime fatigue.</li><li>Impaired performance at school, at work and in social interactions.<ul><li>One study of seasonal allergic conjunctivitis in the UK found a mean reduction of 2.3 hours of productive time/week during allergy season [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Pitt, 2004</a>].</li></ul></li><li>Reduced quality of life.</li></ul></li><li><strong>Vernal and atopic keratoconjunctivitis</strong> are more severe forms of allergic conjunctivitis which can be sight threatening:<ul><li>Vernal keratoconjunctivitis can cause thickening of the eyelids; ptosis; conjunctival scarring; corneal neovascularization, thinning, ulceration, and infection; and loss of vision.</li><li>Atopic keratoconjunctivitis can cause thickening or tightening of the eyelids; loss of eyelashes; conjunctival scarring, neovascularization, thinning, ulceration and infection; loss of vision and cataract.</li></ul></li><li><strong>Conjunctivitis associated with contact lens use</strong><ul><li>Contact lens wear can lead to keratoconjunctivitis or giant cell papillary conjunctivitis — this is more likely to occur if lens hygiene is poor, lenses fit poorly, are worn for long periods of time or are replaced infrequently and if allergy develops to contact lens solution.</li><li>Giant papillary conjunctivitis can lead to intolerance of contact lenses and other ocular foreign bodies such as protheses and sutures.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">American Academy of Ophthalmology, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Ciolino, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Berger, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">BMJ Best Practice, 2017a</a>]</p><!-- end field 3b58b079-4dcf-4dad-afb4-1823ccb947b6 --><!-- end item ed990ecf-56e5-4af6-a087-0473179037b1 -->","topic":{"id":"b4698c45-6b7c-5244-836f-430591327957","topicId":"27f540e5-bb8e-4cee-a0aa-be515efa4fc2","topicName":"Conjunctivitis - allergic","slug":"conjunctivitis-allergic","lastRevised":"Last revised in October 2020","chapters":[{"id":"bc756208-c2a7-5b33-a4cb-67c41a75ecb0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6470bf56-596c-5d66-b2b2-ba79590bb255","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"17755f2a-0980-50f9-b62e-a34968c9682e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b1dc6613-43b4-55fe-9216-a83aab0ef918","slug":"changes","fullItemName":"Changes"},{"id":"ba5e8d6b-90f7-5b69-b09a-2bb0c2692918","slug":"update","fullItemName":"Update"}]},{"id":"fee1ca82-9d2a-50a4-9230-1a93482b8b4f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3d036930-da50-5ea2-82e1-1d0fb936a8b4","slug":"goals","fullItemName":"Goals"},{"id":"9ba6a0ce-0eae-5442-85f0-81f7ff71345b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"48935dfe-bca1-53fa-8d50-fa978331bd56","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35b962f0-ec6b-53c9-b6f2-a5783ae10716","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8e9984f4-8c0d-5231-9eec-91a9fb49ecc4","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8fa3b231-6e2b-5fa2-aa0c-eb5359ff8160","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ebf46a5d-2a79-5df8-82dd-d23fcb0559f1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"67185462-9d0a-5b7d-b8af-80b8958f2420","slug":"definition","fullItemName":"Definition"},{"id":"1c320f1a-b91f-5d5b-a47b-dc0094518883","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b21baf96-f39b-5eeb-934b-c193a434933d","slug":"causes","fullItemName":"Causes"},{"id":"923b6415-5fe1-550a-baf5-89285f8ddf77","slug":"complications","fullItemName":"Complications"},{"id":"a679bff6-4749-539e-bdb0-a762a9f91728","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a7d99d63-f47f-54bf-a60f-8ae6f2a42fb9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"089d5cf7-0f6b-521b-88c1-d4f25eef7101","slug":"assessment","fullItemName":"Assessment"},{"id":"7bb8bdb4-0279-5783-ba21-e44e8bcd0832","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a95dbd6-aaa4-5d6a-aa5b-9635d279f9a0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"51e7c1d5-cd3d-5dea-a8ec-5a38deb58245","fullItemName":"Management","slug":"management","subChapters":[{"id":"e4ced49a-4b06-5559-9efb-c708812a8065","slug":"referral","fullItemName":"Scenario: Referral"},{"id":"77a507ec-4dff-5204-b375-121264b0adf8","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"452bc42e-1fe8-56e6-8511-57362d05fe3f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f9e89c16-d4a7-5241-86f6-1f78eacc68fa","slug":"topical-ocular-antihistamines-mast-cell-stabilizers","fullItemName":"Topical ocular antihistamines and mast cell stabilizers"},{"id":"f9a1678c-7117-5852-af35-628b676780c8","slug":"mast-cell-stabilizers","fullItemName":"Mast cell stabilizers"}]},{"id":"a32b7db8-1764-58b8-adbb-ab8ce0f44e46","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bd1a2d20-e91f-51f1-a2a2-486ebf015f65","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bc4e76de-c203-5f3e-ad9a-b84d6bc9d81e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"565b3a01-b21e-5837-b9f1-49fda55982ad","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b08973ef-af46-5e6f-b85c-d0bd9ca40bab","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3003e52e-8597-505e-a3ce-e46fde4c0c20","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b7947929-e2f9-50c7-b5cd-3e34b802bae1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3819cbbb-ca8c-58b7-b608-0a9567c5d5b5","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ebf46a5d-2a79-5df8-82dd-d23fcb0559f1","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}